Mogrify secures £830k grant funding from SBRI Healthcare
Phase II funding will be used for pre-clinical assessment of regenerative cartilage therapy Follows Phase I SBRI funding, announced in April 2019 Cambridge, UK, 28…
Tag: SBRI
Oxford Drug Design receives over £8m in grant and equity investment
Oxford Drug Design (ODD) wins major funding awards from CARB-X, the UK Department of Health and Social Care (DHSC) and an equity investment led by…
Mogrify subsidiary Chondrogenix secures funding from SBRI
Healthcare to advance regenerative cartilage therapy to the clinic Chondrogenix will use Mogrify’s data-driven conversion platform to generate a safe, efficient and scalable source of…